Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3065625 | Journal of Neuroimmunology | 2007 | 12 Pages |
Abstract
Alzheimer's disease (AD) autoimmunity is a focus for dementia prevention. Generated autoantibodies against major etiopathogenic molecular targets as neuroimmune markers of dementia were measured by ELISA in patient sera. Biphasic antibody levels to Aβ(25–35) oligomers, S100b and DA were detected during distinctly diagnosed dementia stages. Aβ(25–35) oligomer autoimmune responses reflected mild to moderate AD dementia, while those to S100b, DA and the S100b concentrations, matched moderate to severe dementia progression. 5-HT antibodies increased during mild dementia and plateaued thereafter. This autoimmunity pattern may be used as a differential biomarker profile in designing AD therapeutic strategies involving early vaccination.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Marina A. Gruden, Tatyana B. Davidova, Mantas Mališauskas, Robert D.E. Sewell, Nina I. Voskresenskaya, Kristina Wilhelm, Elena I. Elistratova, Vladimir V. Sherstnev, Ludmilla A. Morozova-Roche,